Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Rubén Casado Arroyo"'
Autor:
Rubén Casado Arroyo, Juan Sieira, Maciej Kubala, Decebal Gabriel Latcu, Shigo Maeda, Pedro Brugada
Publikováno v:
Frontiers in Cardiovascular Medicine, Vol 5 (2018)
During last centuries, Early Repolarization pattern has been interpreted as an ECG manifestation not linked to serious cardiovascular events. This view has been challenged on the basis of sporadic clinical observations that linked the J-wave with ven
Externí odkaz:
https://doaj.org/article/ce50a81ff2124611a0b5d03cb6b4544b
Autor:
Francisco Castells, Samuel Ruipérez-Campillo, Izan Segarra, Raquel Cervigón, Rubén Casado-Arroyo, José Luis Merino, José Millet
Publikováno v:
Computers in Biology and Medicine. 154:106604
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9aa94698955302551c7aa9ba583151f3
https://doi.org/10.1016/j.compbiomed.2023.106604
https://doi.org/10.1016/j.compbiomed.2023.106604
Autor:
Rafael Vidal-Perez, Mariana Brandão, Michal Pazdernik, Karl-Patrik Kresoja, Myriam Carpenito, Shingo Maeda, Rubén Casado-Arroyo, Saverio Muscoli, Janine Pöss, Ricardo Fontes-Carvalho, Jose Manuel Vazquez-Rodriguez
Publikováno v:
World journal of clinical cases. 10(27)
Coronavirus disease 2019 (COVID-19) is known to present with respiratory symptoms, which can lead to severe pneumonia and respiratory failure. However, it can have multisystem complications such as cardiovascular manifestations. The cardiovascular ma
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c28e9dafdde55051ea20fc1286b102b0
https://pubmed.ncbi.nlm.nih.gov/36186196
https://pubmed.ncbi.nlm.nih.gov/36186196
Publikováno v:
Archive of Clinical Cases. :48-51
Cardiac complications, such as myocardial disease and arrhythmias, are frequent and may be severe in patients with mitochondrial disease. Mitochondrial diseases are a heterogeneous group of disorders that can affect multiple organs with varying sever
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d15d0be3c6ad5829829ac7e48fcb536d
https://doi.org/10.22551/2014.02.0102.10011
https://doi.org/10.22551/2014.02.0102.10011
Publikováno v:
Heart. 98:718-723
Objective Patients undergoing percutaneous coronary intervention require dual antiplatelet therapy. Proton-pump inhibitor (PPI) therapy is recommended for the prevention of upper GI complications. No study has determined the rate and type of GI bleed
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5e49568b082b9acc588ddcee1ced4e56
https://doi.org/10.1136/heartjnl-2012-301632
https://doi.org/10.1136/heartjnl-2012-301632
Publikováno v:
Enfermedades infecciosas y microbiologia clinica. 33(2)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::5aa4df879d62a0bc035808974d3b4193
https://pubmed.ncbi.nlm.nih.gov/25542339
https://pubmed.ncbi.nlm.nih.gov/25542339
Publikováno v:
Enfermedades Infecciosas y Microbiología Clínica. 33:129-130
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9c1f7789153b51ec9646112e45720f39
https://doi.org/10.1016/j.eimc.2014.07.003
https://doi.org/10.1016/j.eimc.2014.07.003
Publikováno v:
Gastroenterologia y hepatologia. 34(7)
Antiplatelet agents are routinely used in both primary and secondary prevention of cardiovascular events. The development of new antiplatelet agents and the strong growth of interventional cardiology have led to this therapy being more widely prescri
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::eaeb3cd3ef5e427969a7dd9041447728
https://pubmed.ncbi.nlm.nih.gov/21684042
https://pubmed.ncbi.nlm.nih.gov/21684042
Autor:
Shingo Maeda, MD, Kaoru Okishige, MD, Yasuhide Tsuda, MD, Ryo Yonai, MD, Tomoyuki Kawashima, MD, Jackson J. Liang, DO, Ruben Casado Arroyo, MD, Mihoko Kawabata, MD, Hirotsugu Atarashi, MD, Kenzo Hirao, MD
Publikováno v:
JACC: Case Reports, Vol 2, Iss 11, Pp 1766-1770 (2020)
A 75-year-old man was admitted for repeat ablation of atrial fibrillation. At 30 min after infusion of 3.5 ml of ethanol into the vein of Marshall, inferior ST-segment elevation with coronary arterial vasospasm was observed. This is the first report
Externí odkaz:
https://doaj.org/article/ab204a261dec4c8ea789372b40eaf8ad
Autor:
Shingo Maeda, Masahiko Goya, Atsuhiko Yagishita, Yoshihide Takahashi, Mihoko Kawabata, Ruben Casado Arroyo, Kenzo Hirao
Publikováno v:
Journal of International Medical Research, Vol 47 (2019)
The “MINimizE Right Ventricular pacing to prevent Atrial fibrillation and heart failure” (MINERVA) multicenter randomized study demonstrated that atrial anti-tachycardia pacing (A-ATP) can effectively decrease the burden of atrial fibrillation (A
Externí odkaz:
https://doaj.org/article/dcb0af8ba2ce4541bee622dd265a902e